CLINICAL ROLE -
Survey: Retail Pharmacists Optimistic About Biosimilars, Still Have Questions
With the FDA approval and launch of the first interchangeable biosimilar in the United States in 2021, retail pharmacists are poised to play an increasing role in the future uptake of biosimilars.
Read More
Five Key Things Pharmacists Need to Know As Insulin Biosimilars Come to Market
The availability of insulin biosimilars can bring high-quality, lower cost treatment options for pharmacists, physicians, payers, and patients alike.